Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
American Journal of Ophthalmology|October 6, 2000
Orbital T-cell lymphoma in a multiple myeloma patientA Takami, S MizunoyaAnnals of Hematology|January 25, 2002
Menatetrenone, a vitamin K2 analog, ameliorates cytopenia in patients with refractory anemia of myelodysplastic syndromeA Takami, H Asakura, S NakaoAnnals of Hematology|May 29, 1999
Impaired response of granulocyte-committed progenitor cells to stem cell factor and granulocyte colony-stimulating factor in human cyclic neutropeniaA Takami, S Nakao, S Koizumi, et al.Diabetes, Obesity & Metabolism|May 9, 2012
Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)Y Seino, K W Min, E Niemoeller, et al.Cryo Letters|May 15, 2021
Practical and Safe Method of Long-Term Cryopreservation for Clinical Application of Human Adipose-Derived Mesenchymal Stem Cells Without a Programmable Freezer Or SerumS Gao, M Ogawa, A Takami, et al.Environmental Science. Processes & Impacts|April 4, 2019
Emerging investigator series: investigation of mercury emission sources using Hg isotopic compositions of atmospheric mercury at the Cape Hedo Atmosphere and Aerosol Monitoring Station (CHAAMS), JapanA Yamakawa, A Takami, Y Takeda, et al.International Journal of Hematology|January 21, 2000
Successful therapy of myelodysplastic syndrome with menatetrenone, a vitamin K2 analogA Takami, S Nakao, Y Ontachi, et al.Diabetes, Obesity & Metabolism|February 15, 2014
Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metforminY Seino, A Takami, G Boka, et al.British Journal of Haematology|December 22, 1999
Cytotoxicity against lymphoblastoid cells mediated by a T-cell clone from an aplastic anaemia patient: role of CD59 on target cellsA Takami, W Zeng, H Wang, et al.Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|July 4, 2001
[Low dose melphalan therapy was effective in an elderly patient with MDS-AML]Y Ontachi, H Yamauchi, A Takami, et al.Pageof 6